INLB — Item 9 Labs Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Item 9 Labs, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2018 September 30th	2019 September 30th	2020 September 30th	C2021 September 30th	2022 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-Q	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	1.67	0.021	0.085	1.45	0.086
Net Total Accounts Receivable
Net Total Receivables	0.961	0.437	0.353	1.45	0.586
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	3.26	2.96	2.89	10.1	3.55
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.23	7.17	7.41	11	22
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	5.04	14.5	20.7	117	111
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.981	7.14	10.3	15	40.6
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	2.48	7.01	12.6	30.7	48.8
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	2.56	7.46	8.02	86.1	62
Total Liabilities & Shareholders' Equity	5.04	14.5	20.7	117	111
Total Common Shares Outstanding